おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
CANbridge Pharmaceuticals
About
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
- 101 - 250
Highlights
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $43M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2020 | Series E | $43M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series E |
